mHealth-interventie verbetert hypertensiezorg bij hoogrisicopatiënten

Hypertension, Volume 83, Issue 4, Page e26148, April 1, 2026. BACKGROUND:The mGlide RCT (randomized controlled trial) evaluated whether a pharmacist-led, mobile health technology facilitated care model improves hypertension control in diverse populations.METHODS:We recruited adult English, Spanish, or Hmong-speaking patients with uncontrolled hypertension from a large health care system and smaller community clinics serving low-income patients. Participants were randomized 1:1 to mGlide or usual care. The 6-month intervention included daily blood pressure (BP) self-monitoring using a smartphone and wireless monitor, automated app-based data sharing, and responsive medication adjustment by a pharmacist-led provider-team. Comparison participants received a digital monitor. Outcomes included mean 6-month systolic BP (SBP), 12-month sustained BP control, 24-hour ambulatory BP and patient activation.RESULTS:A total of 395 participants (mean age, 66.9 years; 46.6% women; mean [SD] SBP, 143.4